![European American Chamber of Commerce New York [EACCNY] | Your Partner for Transatlantic Business Resources](https://eaccny.com/wp-content/uploads/2020/06/eaccny-logo.png){kind=logo}
Member News
Member News
16
Dec
Geopolitics remains one of the greatest threats to global supply chains. Is AI the solution? At present, AI is already helping to manage several challenges, including climate change, regional tensions, and trade conflicts. In the face of these and other issues, AI can improve things through predictive analytics, optimized logistics, and better resource allocation. This can help supply chains better work through complexities and align with sustainability and regulatory demands while improving visibility, decision-making, and risk management.
The International Air Transport Association...
16
Dec
The United States Patent and Trademark Office (USPTO) has announced significant changes to the patent fee schedule which will take effect on January 19, 2025. The final rule does not include some of the new fee structures proposed in April 2024, but still could have a significant impact on design patent practice, continuing application practice, and Information Disclosure Statement practice.
The changes include new or significant increases to several targeted fees, a 10% increase to all filing fees, and an...
13
Dec
In the Netherlands, Prinsjesdag—or Budget Day—is a key event for businesses, as it outlines the government's tax and financial plans for the coming year. Held every third Tuesday of September (this year on 17th of September), the government presented its budget, highlighting changes to corporate taxes, VAT, wage and income taxes and other policies that affect the business environment. The Miljoenennota (Budget Memorandum) provides details on investments in infrastructure, innovation incentives, and regulatory changes. For businesses, Budget Day is essential for understanding how...
13
Dec
Ireland set for record corporate tax revenue in 2024
November is the most important month of the year in terms of tax collection. The Department of Finance noted how total tax revenues collected to end-November was €99.1 billion, which was 20.8 per cent ahead of November 2023. €22.8 billion in total was collected in November, which is 46.1 per cent higher than in November last year.
Unsurprisingly, corporation tax receipts were the main driver of the increase in tax revenues. Not...
12
Dec
This article examines the legal strategies at play in the regulation of (ordinary) business transactions and decisions in order to achieve optimal alignment between an investor and the board with the goal of increasing value for investors.
1. Introduction
Investing in a company means entrusting your capital to others. As an investor, you'll rely on the company's board and its shareholders to act in your best interest. However, this can give rise to certain challenges, such as managing relationships and ensuring...
09
Dec
We would like to inform you regarding a new reporting obligation that will be implemented starting 1 July 2024. If your company employs at least 100 employees in the Netherlands, you will be required to track and report the total number of kilometers your employees travel for work-related purposes annually. This initiative is part of a government plan to monitor and eventually reduce CO2 emissions linked to business travel.
What travel must be tracked and reported?
The total distance of...
06
Dec
EU extends compliance timeline for landmark Deforestation Regulation
On 3 December, the European Parliament and the Council of the EU reached a provisional agreement to postpone the implementation of the EU’s Regulation on deforestation-free products by one year. This delay extends the deadline for compliance to December 2025 for large companies and June 2026 for SMEs. The decision followed feedback from member states, European political groups, businesses, and non-EU countries, citing challenges in meeting due diligence requirements by the original deadline.
The delay...
05
Dec
The funds will support two Phase 2a clinical trials for the drug candidate CIL001, targeting cochlear synaptopathy (a leading cause of difficulty understanding speech in noise, tinnitus, and hyperacusis), as well as the advancement of preclinical development for the candidate CIL003.
The company will enhance its R&D platform capabilities and establish new strategic partnerships to expand and diversify its portfolio of treatments for hearing disorders.
A special focus will be placed on leveraging advanced artificial intelligence to identify...
Other Chapter News
